Drugs.com - FDA MedWatch Alerts

CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags Due to Visible Black Particulate Matter in a Single-Sealed Vial

Audience: Pharmacy, Health Care Professional February 24, 2025 – Bethlehem, PA. Central Admixture Pharmacy is recalling three lots of Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags (NDC: 71285-6092-1) to the...

Feb 26, 2025 - 05:20
 0
CAPS Issues Recall of Phenylephrine 40 mg Added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags Due to Visible Black Particulate Matter in a Single-Sealed Vial
Audience: Pharmacy, Health Care Professional February 24, 2025 – Bethlehem, PA. Central Admixture Pharmacy is recalling three lots of Phenylephrine 40 mg added to 0.9% Sodium Chloride 250 mL in 250 mL Excel Bags (NDC: 71285-6092-1) to the...
Read More

Tags:

Previous Article

Here's Where IndiGo Is Flying With its First Widebody Flight

Next Article

Unlock the Future of Hospitality and Travel: What Awaits at ITB Berlin 2025

Related Posts

FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

FDA, FTC Continue Joint Effort to Protect Consumers Aga...

Feb 9, 2025  0

Drug Safety Communication: FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause

Drug Safety Communication: FDA Adds Warning About Rare ...

Feb 9, 2025  0

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Iss...

Feb 9, 2025  0